Anti-TNF therapy from the bench to the clinic: a paradigm of translational research

被引：7

作者：

Maini, Ravinder N. ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Div Rheumatol, Kennedy Inst, London SW7 2AZ, England

来源：

CLINICAL MEDICINE | 2010年 / 10卷 / 02期

关键词：

NECROSIS-FACTOR-ALPHA; CARTILAGE PANNUS JUNCTION; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; INTERLEUKIN-1; METHOTREXATE; LOCALIZATION; COMBINATION; TRIAL; CA2;

D O I：

10.7861/clinmedicine.10-2-161

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：161 / 162

页数：2

共 16 条

[1]

The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment [J].

Breedveld, FC ;

Weisman, MH ;

Kavanaugh, AF ;

Cohen, SB ;

Pavelka, K ;

van Vollenhoven, R ;

Sharp, J ;

Perez, JL ;

Spencer-Green, GT .

ARTHRITIS AND RHEUMATISM, 2006, 54 (01) :26-37

[2]

BRENNAN FM, 1989, LANCET, V2, P244

[3]

BUCHAN G, 1988, CLIN EXP IMMUNOL, V73, P449

[4]

LOCALIZATION OF TUMOR-NECROSIS-FACTOR-ALPHA IN SYNOVIAL TISSUES AND AT THE CARTILAGE PANNUS JUNCTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].

CHU, CQ ;

FIELD, M ;

FELDMANN, M ;

MAINI, RN .

ARTHRITIS AND RHEUMATISM, 1991, 34 (09) :1125-1132

[5]

CACHECTIN TUMOR NECROSIS FACTOR STIMULATES COLLAGENASE AND PROSTAGLANDIN-E2 PRODUCTION BY HUMAN SYNOVIAL-CELLS AND DERMAL FIBROBLASTS [J].

DAYER, JM ;

BEUTLER, B ;

CERAMI, A .

JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (06) :2163-2168

[6]

LOCALIZATION OF TUMOR-NECROSIS-FACTOR RECEPTORS IN THE SYNOVIAL TISSUE AND CARTILAGE PANNUS JUNCTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS - IMPLICATIONS FOR LOCAL ACTIONS OF TUMOR-NECROSIS-FACTOR-ALPHA [J].

DELEURAN, BW ;

CHU, CQ ;

FIELD, M ;

BRENNAN, FM ;

MITCHELL, T ;

FELDMANN, M ;

MAINI, RN .

ARTHRITIS AND RHEUMATISM, 1992, 35 (10) :1170-1178

[7]

RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS [J].

ELLIOTT, MJ ;

MAINI, RN ;

FELDMANN, M ;

KALDEN, JR ;

ANTONI, C ;

SMOLEN, JS ;

LEEB, B ;

BREEDVELD, FC ;

MACFARLANE, JD ;

BIJL, H ;

WOODY, JN .

LANCET, 1994, 344 (8930) :1105-1110

[8]

ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362

[9]

REPEATED THERAPY WITH MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].

ELLIOTT, MJ ;

MAINI, RN ;

FELDMANN, M ;

LONGFOX, A ;

CHARLES, P ;

BIJL, H ;

WOODY, JN .

LANCET, 1994, 344 (8930) :1125-1127

[10]

Anti-TNFα therapy of rheumatoid arthritis:: what have we learned? [J].

Feldmann, M ;

Maini, RN .

ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :163-196

← 1 2 →